A detailed history of Post Resch Tallon Group Inc. transactions in Amgen Inc stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 1,041 shares of AMGN stock, worth $300,713. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,041
Holding current value
$300,713
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$258.78 - $328.31 $269,389 - $341,770
1,041 New
1,041 $270 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Post Resch Tallon Group Inc. Portfolio

Follow Post Resch Tallon Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Post Resch Tallon Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Post Resch Tallon Group Inc. with notifications on news.